PERformance of Multi-Cancer Early-detectIon Based on Various Biomarkers in fEmale BREAST Cancers, PERCEIVE-BREAST

Active, not recruitingOBSERVATIONAL

Enrollment

496

Participants

Timeline

Start Date

July 10, 2021

Primary Completion Date

May 31, 2023

Study Completion Date

December 30, 2026

Conditions

Cancer

Interventions

DEVICE

Blood test

Trial Locations (2)

The Affiliated Hospital of Medical College Qingdao University, Qingdao

Jiangsu Provincial People's Hospital, Nanjing

All Listed Sponsors

collaborator

Guangzhou Bruning Rock Bioengineering Ltd

UNKNOWN

lead

The First Affiliated Hospital with Nanjing Medical University

OTHER